Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Utilize diversification as a key strategy for wealth preservation. Safeguard your investments against market fluctuations.
23,542 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Salesforce just delivered a solid quarter with revenue and adjusted earnings topping expectations and a $50 billion b...
Oil prices surged into the high $70s as traffic through the Strait of Hormuz halted, stoking fears of tighter supply....
Alibaba’s AI models project sharp upside for XRP, Bitcoin and Ethereum by the end of 2026. The forecasts come as mark...
A shifting market backdrop has investors turning to high-yield, dividend-growing names. Three dividend king stocks th...
The U.S. and allies are releasing barrels from reserves to ease rising gas costs, but analysts caution the relief may...
A prominent investor dumped a multi‑million stake in a biotech stock that’s up double digits. This article explains w...
In 2026, unicorns flush with cash face a new bottleneck: cap table gridlock. Despite record funding, ownership comple...
QVC is leaning into TikTok's live shopping fever as traditional TV fades. The move aims to spark a new growth engine ...
Tariffs are pitched as a way to strengthen the economy, but the reality is more complicated. This article breaks down...
Apyx Medical (APYX) 2026 is shaping up as a pivotal year for investors. This guide breaks down how to read the Q1 tra...
As CleanSpark gears up for its 2026 earnings season, investors wonder how mining economics, energy initiatives, and c...